We are proud to announce a collection edited by Andy T. Y. Lau and Amy Yan-Ming Xu. We welcome articles on a range of topics including, but not limited to: novel functions of cancer-specific and systematic analysis of human proteoforms; cancer-specific proteoforms as diagnostic biomarkers or therapeutic targets, and the development of novel strategies to modulate proteoforms function in cancer therapy.
Cancer Cell International, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
Cancer Cell International publishes articles on all aspects of cancer cell biology originating from work using laboratory experimentation. Read more here.
Yasumasa Kato, Ohu University, Japan
Andy TY Lau, Shantou University Medical College, China
2021 marked the 20th year since Cancer Cell International published its very first articles. To mark the occasion, we're looking back at the journal's milestone achievements and highlighting some of the best content from the past 20 years.
Click here to view which articles have been shared the most in the last month!
Discover the range of academic oncology titles at Springer Nature here.
Your browser needs to have JavaScript enabled to view this timeline
2022 Citation Impact
5.8 - 2-year Impact Factor
5.6 - 5-year Impact Factor
0.994 - SNIP (Source Normalized Impact per Paper)
1.145 - SJR (SCImago Journal Rank)
2023 Speed
34 days submission to first editorial decision for all manuscripts (Median)
110 days submission to accept (Median)
2023 Usage
2,067,719 downloads
1,052 Altmetric mentions
06 April 2023
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).